Sienna Biopharmaceuticals, Inc. — Form D/A

Sienna Biopharmaceuticals, Inc. of Weslake Village, CA, a company, filed a Form D amendment with the SEC on 2017-05-15. The offering totals $50.0M, of which $46.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Robert NelsonDirectorShreveport, LA
Kristina BurowDirectorSan Diego, CA
Timothy K AndrewsExecutive OfficerSan Diego, CA
Robert MoreDirectorCarlsbad, CA
Robert MoreExecutive OfficerCarlsbad, CA
Todd HarrisDirectorSan Juan Capistrano, CA
Todd HarrisExecutive OfficerSan Juan Capistrano, CA
Dennis R FentonDirectorWestlake Village, CA
Bob R MoreDirectorWestlake Village, CA
Diane F StroehmannExecutive OfficerWestlake Village, CA
Frederick C Beddingfield IIIDirectorWestlake Village, CA
Frederick C Beddingfield IIIExecutive OfficerWestlake Village, CA
Paul F LizzulExecutive OfficerWestlake Village, CA
Ric C PetersonExecutive OfficerWestlake Village, CA
Keith R Leonard Jr.DirectorWestlake Village, CA
Todd C HarrisDirectorWestlake Village, CA
Todd C HarrisExecutive OfficerWestlake Village, CA
Robert R NelsenDirectorWestlake Village, CA
Kristina R BurowDirectorWestlake Village, CA
Ted SchwarzExecutive OfficerCarlsbad, CA
Frederick BeddingfieldDirectorCarlsbad, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2017-05-15D$40.5M$40.5M
2015-10-20D$40.4M$18.5M

More